203 results on '"Theilade, Simone"'
Search Results
2. Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes
3. Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes
4. Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes
5. Treatment options for hypercalcemia after cosmetic oil injections: Lessons from human tissue cultures and a pilot intervention study
6. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
7. Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study
8. Ceramides as risk markers for future cardiovascular events and all-cause mortality in long-standing type 1 diabetes
9. Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes
10. Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes.
11. Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients—the Thousand & 1 Study
12. Ceramides as risk markers for future cardiovascular events and all-cause mortality in long-standing type 1 diabetes
13. A marker of type VI collagen formation (PRO-C6) is associated with higher arterial stiffness in type 1 diabetes
14. Metabolomic Risk Predictors of Diabetic Foot Complications: a longitudinal observational study
15. Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism
16. Additional file 1 of Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes
17. Pulse wave reflection is associated with diabetes duration, albuminuria and cardiovascular disease in type 1 diabetes
18. Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness
19. 3.7 Pulse Wave Velocity is an Independent Risk Factor for Cardiovascular Events, Mortality and Decline in Renal Function in Patients with Type 1 Diabetes
20. Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
21. P153: Marker of Type VI Collagen Formation (Pro-C6) is associated with Higher Arterial Stiffness in Type 1 Diabetes
22. Cardiovascular Autonomic Neuropathy in Type 1 Diabetes is Associated with Several Metabolic Pathways – New Risk Markers on the Horizon
23. An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weight
24. Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes
25. Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes
26. Visit‐to‐visit variability of clinical risk markers in relation to long‐term complications in type 1 diabetes
27. Hypercalcemia After Cosmetic Oil Injections: Unraveling Etiology, Pathogenesis, and Severity
28. Carotid‐Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus
29. Arterial Stiffness Is Associated With Cardiovascular, Renal, Retinal, and Autonomic Disease in Type 1 Diabetes
30. Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes.
31. Circulating Metabolites and Lipids Are Associated to Diabetic Retinopathy in Individuals With Type 1 Diabetes
32. Circulating metabolites and lipids are associated to diabetic retinopathy in individuals with type 1 diabetes
33. SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease
34. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
35. The prevalence and relevance of the Brugada-type electrocardiogram in the Danish general population: data from the Copenhagen City Heart Study
36. Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes
37. Visit‐to‐visit variability of clinical risk markers in relation to long‐term complications in type 1 diabetes.
38. Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 Diabetes
39. Targeted Clinical Metabolomics Platform for the Stratification of Diabetic Patients
40. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes
41. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes
42. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes
43. Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
44. Hypercalcemia After Cosmetic Oil Injections: Unraveling Etiology, Pathogenesis, and Severity.
45. PRO-C3 as a Risk Marker for Kidney Disease Progression and Mortality in Type 1 Diabetes
46. MOESM1 of Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies
47. Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetes
48. Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies
49. Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 Diabetes
50. Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping: a randomised, placebo-controlled, double-blind cross-over trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.